Twice the output, half the runtime, and half the footprint of the UG 100® with greater flexibility and improved genomic coverage Introducing two new high-throughput instrument configurations ...
Rapid expansion in clinical applications, rising demand for genomic diagnostics, and increased investment in CRISPR-based ...
Next-generation sequencing (NGS), especially long-read DNA sequencing, is transforming infectious organism detection by ...
Brian Tait calls for public support to fund exciting groundbreaking technology for assigning phase to multiple mutations ...
Natera NTRA announced the commercial launch of Zenith genomics, a next-generation whole genome sequencing assay designed to improve the detection and diagnosis of rare genetic diseases. The core ...
Life sciences and diagnostics company Revvity has had a busy couple of years, playing a major role in the next-generation sequencing-based screening of newborns to better enable healthcare ...
Profusa (PFSA) shares jumped 173% following announcement of $30M equity deal to acquire PanOmics diagnostics platform from BioInsights LLC.
Unlock the latest liquid biopsy market data. Explore growth drivers, precision oncology shifts, and the tech fueling ...
Located on the Buffalo Niagara Medical Campus and the first next-generation sequencing service provider in the region, UB's Genomics and Bioinformatics Core Facility provides high-quality services ...